Associated Papers
RET Aberrations in Diverse Cancers: Next-Generation Sequencing of 4,871 Patients.
Kato S et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2017
27683183 (PubMed )
Supplement: 10780432ccr161679-sup-168576_1_supp_3636667_wcc1ns.docx
Development and clinical application of an integrative genomic approach to personalized cancer therapy.
Uzilov AV et al.
Genome Medicine, 2016
CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.
Costa-Cabral S et al.
Plos One, 2016
26881434 (PubMed )
Supplement: pone.0149099.s013.xlsx › S2_Table
Select a paper to view details